Commodore Capital’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Commodore Capital's SGMT Position: Q3 2026 in Review
Commodore Capital opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 2,757,742 shares worth $27.2M. The stake represents 2.11% of the portfolio and ranks #15 among its holdings.
147 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Commodore Capital held 2,757,742 shares of Sagimet Biosciences worth $27.2M as of Q3 2026.
- Sagimet Biosciences was a new Commodore Capital position in Q3 2026.
- Sagimet Biosciences made up 2.11% of Commodore Capital's portfolio in Q3 2026, its #15 holding.
- 147 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.